This content is machine translated Cardiovascular complications Late effects of oncological diseases Thanks to state-of-the-art diagnostic and therapeutic options, almost all children and adolescents who develop cancer can be cured today. However, the consequences of such hemato-oncological treatment should not be ignored.…
View Post 3 min This content is machine translated Breast Cancer BRCA mutations and their consequences Breast carcinoma is the most common malignant tumor of the mammary gland. In particular, mutations of the BRCA genes significantly increase the risk of disease, which is why genetic testing…
View Post 5 min This content is machine translated Psychooncology The importance of certification-relevant stress screenings Psycho-oncological support needs do not necessarily think of themselves in terms of patient distress. A sensitive and step-by-step approach is therefore indicated in order to uncover possible ambivalences.
View Post 1 min This content is machine translated Squamous cell carcinoma Pembrolizumab as first-line therapy reduces mortality rate In a phase III trial, pembrolizumab improved overall survival in patients with recurrent or metastatic head and neck squamous cell carcinoma.
View Post 4 min This content is machine translated Dermato-Oncology New strategies in the fight against skin cancer The latest dermato-oncological studies on prevention, diagnosis and therapy were the subject of the German Skin Cancer Congress. There are promising developments in melanoma therapy, in the treatment of basal…
View Post 9 min This content is machine translated Thyroid carcinomas State of the Art Therapy Thyroid carcinomas can be diagnosed well today thanks to modern imaging techniques and often have a good prognosis. However, postoperative risk stratification should take place at a center with a…
View Post 3 min This content is machine translated Colorectal Cancer Focus on combination therapies Triple for colorectal cancer – for the first time, studies have shown clear superiority of a triple combination of encorafenib, binimetinib and cetuximab in progressive metastatic colorectal tumors.
View Post 1 min This content is machine translated Tumor-associated thromboembolism Oral anticoagulation with NOAKs? Tumor-associated thromboembolism can have fatal consequences. Therefore, effective anticoagulation is indicated in the acute situation and as recurrence prophylaxis. Currently, heparins are recommended. Can NOAKs also be used?
View Post 2 min This content is machine translated BCL-2 Inhibition The next chapter in blood cancer therapy is opened BCL-2 inhibition represents a milestone in the history of blood cancer treatment. Approved for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL), oral small molecule is now also…
View Post 2 min This content is machine translated Juvenile Oncology Keeping an eye on the late effects Even if children survive a malignancy, they are still at risk. Late effects resulting from therapy should not be taken lightly.
View Post 2 min This content is machine translated CAR-T cells Focus on innovative cancer therapy CAR-T cells are currently one of the most exciting developments in immunotherapy. It combines immunotherapy, cell therapy and gene therapy and could become a routine treatment in the future.
